Do local anesthetics exhibit cross‑allergy between different agents (e.g., between ester‑type and amide‑type drugs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cross-Allergy Between Local Anesthetics

Cross-reactivity between ester-type and amide-type local anesthetics is rare, making it safe to switch between these two chemical classes when a patient has a documented allergy to one group. 1, 2

Chemical Classification and Cross-Reactivity Patterns

Local anesthetics are divided into two distinct chemical classes with different cross-reactivity profiles:

Between Ester and Amide Classes

  • Cross-reactivity between ester-type (e.g., tetracaine, procaine, chloroprocaine) and amide-type (e.g., lidocaine, bupivacaine, mepivacaine, ropivacaine) local anesthetics is rare. 1, 2
  • The American Academy of Dermatology guidelines specifically recommend switching to an amide-type local anesthetic for patients with documented ester-type allergies. 1, 2
  • When cross-reactions do occur between these classes, they are usually attributed to paraben preservatives in amide preparations or co-sensitization rather than true cross-reactivity. 1, 3

Within the Amide Class

  • Cross-reactivity within the amide group is not scarce and occurs in a clinically significant proportion of cases. 4, 5
  • Lidocaine-mepivacaine cross-reactivity has been documented in all six cases where cross-reactivity was identified in one major case series. 4
  • Cross-reactivity between levobupivacaine and ropivacaine has been reported with negative reactions to articaine and lidocaine in the same patient. 6
  • Prilocaine can cross-react with articaine but not necessarily with other amide anesthetics. 7
  • Mepivacaine has shown cross-reactivity with lidocaine and ropivacaine, but not with bupivacaine or levobupivacaine in documented cases. 8

Within the Ester Class

  • Patients allergic to one ester-type anesthetic (e.g., tetracaine) often cross-react with other esters (e.g., procaine, chloroprocaine). 2

Clinical Management Algorithm

For Patients with Documented Ester-Type Allergy:

  1. Switch to any amide-type local anesthetic (lidocaine, bupivacaine, mepivacaine, ropivacaine, articaine) as cross-reactivity is rare. 1, 2
  2. No skin testing is typically required before using an amide agent. 1

For Patients with Documented Amide-Type Allergy:

  1. Do not assume other amides are safe—cross-reactivity within the amide class occurs frequently enough to warrant caution. 4, 5
  2. Perform skin testing (prick test, intradermal testing at 1:100 dilution, and challenge tests) with multiple alternative amide local anesthetics before use. 4, 5
  3. The negative predictive value of intradermal testing at 1:100 dilution is high (97.56%) for immediate-type reactions. 5
  4. Consider switching to an ester-type local anesthetic if all amides test positive. 1

Alternative Options When Both Classes Are Contraindicated:

  • 1% diphenhydramine (onset 5 minutes vs. 1 minute for lidocaine, with limited efficacy). 1, 3
  • Bacteriostatic normal saline (0.9% benzyl alcohol in normal saline), which may be less painful than diphenhydramine when combined with epinephrine. 1, 3

Critical Clinical Considerations

Identifying True Allergy vs. Other Reactions:

  • True immunologic reactions to local anesthetics represent only 1% of all adverse reactions. 1, 9, 3
  • Most "allergic reactions" are actually due to inadvertent intravascular injection, systemic epinephrine absorption, vasovagal reactions, or preservative reactions (methylparaben, metabisulfites). 9, 2, 3
  • Independent risk factors for true LA allergy include: personal history of ADR with local anesthetics (RR=4.007), generalized cutaneous symptoms during past reaction (RR=9.043), and hypotension during past reaction (RR=10.445). 5

Testing Recommendations:

  • Because cross-reactivity within the amide class is unpredictable, skin tests should involve several local anesthetics, not just one alternative. 4, 7
  • Testing should include prick tests, intradermal reactions, and challenge tests to confirm both the diagnosis and identify safe alternatives. 4, 5
  • In emergency situations without allergy testing available, avoid all drugs in the same chemical class as the known allergen. 2

Common Pitfall:

  • Do not assume that all amide local anesthetics are interchangeable in allergic patients—the evidence clearly demonstrates that cross-reactivity within this class occurs with sufficient frequency to require individual testing of alternative agents. 4, 7, 5, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Local Anesthetic Allergy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lidocaine Administration and Drug Eruption Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Contact allergy and cross-reactions caused by prilocaine.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society, 1997

Research

Cross-reactivity among amide-type local anesthetics in a case of allergy to mepivacaine.

Journal of investigational allergology & clinical immunology, 2006

Guideline

Prevalence and Epidemiology of Bupivacaine Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.